Yann04
Senior Member (Voting Rights)
No abstract Provided.
Here’s an excerpt instead:
In this pre-registered (DRKS00031294) randomized, double-blind and sham-controlled trial we assessed the efficacy of repetitive anodal tDCS over the left dorsolateral prefrontal cortex (dlPFC) in 40 long COVID patients with cognitive fatigue. Patients underwent four consecutive daily sessions of either 30 minutes active (1.5mA) or sham stimulation, with assessments before treatment, one day post-treatment, and at a one-month follow-up (Fig. 1A). The primary outcome measure was subjective cognitive trait fatigue, assessed through the Modified Fatigue Impact Scale (MFIS) cognitive subscore. Assessments additionally included the assessment of depressive symptoms, quality of life as well as an EEG measurement to capture objective trait fatigue [9]. See Supplementary Material for details on study design, randomization, intervention and statistical analysis.
The results revealed significant improvements in MFIS cognitive scores for both, the active and sham stimulation group, with these benefits lasting up to one month following the intervention (Fig. 1Ci). We observed a statistical significant reduction in subjective trait fatigue ratings from pre-to post-assessment (mean difference = 2.38, p < .001) and from pre-assessment to follow-up (mean difference = 3.35, p < .001) across all participants. A further, non-significant reduction was noted from post-assessment to follow-up (mean difference = 0.98, p = .095). Although these improvements were not exclusive to the active stimulation group, it is essential to highlight that both groups experienced substantial reductions in their so far treatment-resistant cognitive fatigue. This finding is noteworthy given the current lack of effective treatments for long-term fatigue associated with long COVID.
https://www.brainstimjrnl.com/article/S1935-861X(25)00064-6/fulltext
(Open Access)
Here’s an excerpt instead:
In this pre-registered (DRKS00031294) randomized, double-blind and sham-controlled trial we assessed the efficacy of repetitive anodal tDCS over the left dorsolateral prefrontal cortex (dlPFC) in 40 long COVID patients with cognitive fatigue. Patients underwent four consecutive daily sessions of either 30 minutes active (1.5mA) or sham stimulation, with assessments before treatment, one day post-treatment, and at a one-month follow-up (Fig. 1A). The primary outcome measure was subjective cognitive trait fatigue, assessed through the Modified Fatigue Impact Scale (MFIS) cognitive subscore. Assessments additionally included the assessment of depressive symptoms, quality of life as well as an EEG measurement to capture objective trait fatigue [9]. See Supplementary Material for details on study design, randomization, intervention and statistical analysis.
The results revealed significant improvements in MFIS cognitive scores for both, the active and sham stimulation group, with these benefits lasting up to one month following the intervention (Fig. 1Ci). We observed a statistical significant reduction in subjective trait fatigue ratings from pre-to post-assessment (mean difference = 2.38, p < .001) and from pre-assessment to follow-up (mean difference = 3.35, p < .001) across all participants. A further, non-significant reduction was noted from post-assessment to follow-up (mean difference = 0.98, p = .095). Although these improvements were not exclusive to the active stimulation group, it is essential to highlight that both groups experienced substantial reductions in their so far treatment-resistant cognitive fatigue. This finding is noteworthy given the current lack of effective treatments for long-term fatigue associated with long COVID.
https://www.brainstimjrnl.com/article/S1935-861X(25)00064-6/fulltext
(Open Access)